protalix management
「protalix management」熱門搜尋資訊
「protalix management」文章包含有：「Aboutus」、「ProtalixBioTherapeutics」、「Protalix」、「ProtalixBioTherapeutics」、「Contacts」、「ProtalixBioTherapeuticsInc」、「ProtalixBiotherapeutics」、「ProtalixBioTherapeuticstoAnnounceSecondQuarter...」、「ProtalixBioTherapeuticstoAnnounceFirstQuarter2024...」、「ProCellEx®Platform」
查看更多
About us
https://protalix.com
Management · Dror Bashan. Mr. Bashan has served as our President and Chief Executive Officer and as our director since June 2019. · Eyal Rubin. Mr. Rubin has ...
Protalix BioTherapeutics
http://ir.protalix.com
Protalix is a biopharmaceutical company focused on the development, production, and commercialization of innovative medicines for patients living with rare ...
Protalix
https://protalix.com
Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx ...
Protalix BioTherapeutics
https://simplywall.st
Management criteria checks 3/4 ... Protalix BioTherapeutics' CEO is Dror Bashan, appointed in Jun 2019, has a tenure of 5.08 years. total yearly compensation is ...
Contacts
https://protalixbiotherapeutic
Management · Board of Directors · Scientific Advisory Board · Environmental ... [email protected]. Other information: [email protected]. Shareholder Tools. Print ...
Protalix BioTherapeutics Inc
https://www.globaldata.com
The following section provides information on Protalix BioTherapeutics Inc's senior management, executives, CEO and key decision makers and their roles in the ...
Protalix Biotherapeutics
https://tw.linkedin.com
Protalix (NYSE American, TASE: PLX) is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins ...
Protalix BioTherapeutics to Announce Second Quarter ...
https://www.prnewswire.com
Management will host a conference call with investors to discuss the financial results and provide an update on recent corporate and ...
Protalix BioTherapeutics to Announce First Quarter 2024 ...
https://protalixbiotherapeutic
Management will host a conference call with investors to discuss the financial results and provide an update on recent corporate and regulatory developments.
ProCellEx®Platform
https://protalix.com
ProCellEx® is our proprietary platform used to produce and manufacture recombinant proteins through plant cell-based expression systems.